CRH Reports Record 2025 Financials with Double-Digit EBITDA Growth, Strategic Acquisitions, and Increased Shareholder Returns
summarizeSummary
CRH delivered record financial results in 2025 with double-digit growth in Adjusted EBITDA and EPS, fueled by strategic acquisitions and a positive market outlook. The company also increased its dividend and continued its share buyback program.
check_boxKey Events
-
Record Financial Performance in 2025
Total revenues increased to $37.4 billion (up 5%), Net income rose to $3.8 billion, and Adjusted EBITDA grew to $7.7 billion (up from $6.9 billion in 2024). Diluted EPS reached $5.51, up from $5.02 in 2024.
-
Significant Strategic Acquisitions
The company completed 38 acquisitions totaling $4.1 billion in 2025, with the largest being the $2.1 billion acquisition of Eco Material Technologies, a leading supplier of supplementary cementitious materials in North America.
-
Increased Shareholder Returns
CRH returned $1.2 billion to shareholders through share buybacks (11.7 million shares) and increased its full-year dividend per share by 5.7% to $1.48.
-
Positive Outlook for 2026
Management anticipates favorable underlying demand across key end-markets, supported by significant public investment in infrastructure and continued reindustrialization activity.
auto_awesomeAnalysis
CRH's annual 10-K filing confirms robust financial performance for fiscal year 2025, building on the preliminary results announced in the prior day's 8-K. The report details significant growth across key metrics, driven by strategic acquisitions and disciplined execution. The company's active portfolio management is evident with substantial acquisitions, including the $2.1 billion purchase of Eco Material Technologies, and a post-period divestiture. Strong capital allocation is highlighted by increased dividends and a considerable share buyback program. The positive outlook for 2026, underpinned by infrastructure spending and reindustrialization, reinforces investor confidence. The unqualified audit opinion on both financial statements and internal controls further strengthens the report's positive sentiment.
At the time of this filing, CRH was trading at $123.15 on NYSE in the Manufacturing sector, with a market capitalization of approximately $83.5B. The 52-week trading range was $76.75 to $131.55. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.